Why Is a Major Shareholder of NASDAQ-Listed Aclaris Therapeutics Investing Millions More in Company Shares? A Deep Dive
Braden Michael LEONARD, a major shareholder of Aclaris Therapeutics, Inc., listed on the NASDAQ exchange under ticker ACRS, has been actively purchasing his own company’s stocks. In the last few weeks, he disclosed buying 4,052,031 shares with his own funds, totalling $4,557,727.69, through SEC EDGAR filings. He now holds 13,181,664 shares, which are valued at […]